About Peter Lee, MD
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Peter Lee, MD
During the past decade, Peter Lee, MD conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Peter Lee, MD
According to Clinical.Site data, the most researched conditions in "Peter Lee, MD" are
"Digital Ulcers" (2 trials) and "Systemic Sclerosis" (1 trials). Many other conditions were trialed in "Peter Lee, MD" in a lesser frequency.
Clinical Trials Intervention Types at Peter Lee, MD
Most popular intervention types in "Peter Lee, MD" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bosentan 125 mg" (2 trials), "Bosentan 62.5 mg" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Peter Lee, MD
The vast majority of trials in "Peter Lee, MD" are
2 trials for "All" genders.
Clinical Trials Status at Peter Lee, MD
Currently, there are NaN active trials in "Peter Lee, MD".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Peter Lee, MD,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Peter Lee, MD, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".